Page last updated: 2024-09-05

doranidazole and Carcinoma, Epidermoid

doranidazole has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kishii, K; Kobayashi, A; Kubota, N; Masui, S; Yahiro, T; Yamada, K	1

Other Studies

1 other study(ies) available for doranidazole and Carcinoma, Epidermoid

Article	Year
Effects of hypoxic cell radiosensitizer doranidazole (PR-350) on the radioresponse of murine and human tumor cells in vitro and in vivo. Journal of radiation research, 2005, Volume: 46, Issue:3 Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Radiation; Humans; Imidazoles; Mice; Oxygen; Pancreatic Neoplasms; Radiation Dosage; Radiation-Sensitizing Agents	2005

Article

Year

Effects of hypoxic cell radiosensitizer doranidazole (PR-350) on the radioresponse of murine and human tumor cells in vitro and in vivo.

Journal of radiation research, 2005, Volume: 46, Issue:3

Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Radiation; Humans; Imidazoles; Mice; Oxygen; Pancreatic Neoplasms; Radiation Dosage; Radiation-Sensitizing Agents

2005